TELA Bio, Inc. (TELA) vs Tenax Therapeutics, Inc. (TENX)

A side-by-side comparison of TELA Bio, Inc. and Tenax Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — TELA vs TENX

growth of $100 · dividends reinvested · last 7y
TELA -91.5% (-29.6%/yr)TENX -99.9% (-62.7%/yr)TELA compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $100202120232025$9$0
TELA TENX

TELA vs TENX: by the numbers

  • •TENX is the larger company ($51M vs $49M market cap).
  • •Both run net losses; TENX's is the smaller (0.00% vs -51.53% net margin).

Metrics side by side

Valuation

MetricTELATENX
P/S ratio0.61N/A
P/B ratioN/A0.45

Profitability

MetricTELATENX
Gross margin67.81%0.00%
Operating margin-42.56%0.00%
Net margin-51.53%0.00%
ROEN/A-57.10%
ROIC-80.88%-60.40%

Growth (annualized)

MetricTELATENX
Revenue CAGR (5Y)26.77%N/A
Total return CAGR (5Y)-38.71%-76.80%

Frequently asked

How have TELA and TENX total returns compared?
Over the past 5 years, TELA delivered -38.71% and TENX delivered -76.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.